In this study, we found for the first time that higher ApoA1 levels were strongly associated with a higher risk of osteoporosis, which not only fills this knowledge gap, but also suggests that lipids with cardiovascular benefits may be detrimental to osteoporosis, and moreover, provides a reference and theoretical basis for the development of treatment strategies appropriate for specific populations. This evidence concerns the gene APOA1 and osteoporosis.